A multicenter, randomized, double-blind, placebo controlled phase III study of monosialoganglioside (GM1) preventing neurotoxicity induced by cisplatin-based chemotherapy in non-small cell lung cancer patients.

被引：0
|
作者：
Zhang, Li
Zhou, Ting
Ma, Yuxiang
Yang, Yunpeng
Fang, Wenfeng
Zhao, Yuangyuan
Hong, Shaodong
Fang, Chan
Zhang, Jiexia
Zhang, Hongyu
Zhao, Hongyun
Huang, Yan
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[2] Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[3] Hosp Tradit Chinese Med Zhongshan, Zhongshan, Peoples R China
[4] China State Key Lab Resp Dis, Guangzhou, Peoples R China
[5] Guangzhou Inst Resp Dis, Guangzhou, Peoples R China
[6] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China
[8] Sun Yat Sen Univ, Caner Ctr, State Key Lab Oncol South China, Guangzhou, Peoples R China
[9] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.TPS10142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS10142
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)
    Scagliotti, G.
    Vynnychenko, I.
    Ichinose, Y.
    Park, K.
    Kubota, K.
    Blackhall, F. H.
    Pirker, R.
    Galiulin, R.
    Ciuleanu, T.
    Sydorenko, O.
    Dediu, M.
    Papai-Szekely, Z.
    Banaclocha, N. Martinez
    Mccoy, S.
    Yao, B.
    Hei, Y. J.
    Spigel, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [42] An international, randomized, placebo-controlled, double-blind phase III study (MONET1) of motesanib plus carboplatin/paclitaxel (C/P) in patients with advanced nonsquamous non-small cell lung cancer (NSCLC)
    Scagliotti, G.
    Vynnychenko, I.
    Ichinose, Y.
    Park, K.
    Kubota, K.
    Blackhall, F. H.
    Pirker, R.
    Galiulin, R.
    Ciuleanu, T.
    Sydorenko, O.
    Dediu, M.
    Papai-Szekely, Z.
    Banaclocha, N. Martinez
    McCoy, S.
    Yao, B.
    Hei, Y. J.
    Spigel, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Nedaplatin- versus cisplatin-based chemotherapy in the survival time of patients with non-small cell lung cancer
    Shan, Jinlu
    Xiong, Yanli
    Wang, Dong
    Xu, Mingfang
    Yang, Yi
    Gong, Kan
    Yang, Zhenzhou
    Wang, Ge
    Yang, Xueqin
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (03) : 543 - 549
  • [44] A multicenter, randomized, double-blind, phase III study of gefitinib in combination with anlotinib or placebo in previously untreated patients with EGFR mutation-positive advanced non-small cell lung cancer (FL-ALTER)
    Zhang, L.
    Fang, W.
    Yu, Q.
    Zhang, H.
    Wu, G.
    Wu, D.
    Lin, Y.
    Zhu, J.
    Chen, J.
    Hu, X.
    Lan, B.
    Zhou, Z.
    Lin, H.
    Wang, Z.
    Lei, X.
    Pan, S.
    Chen, L.
    Zhang, J.
    Kong, T.
    Yu, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1562 - S1562
  • [45] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response
    Vansteenkiste, JF
    Colowick, AB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 762 - 763
  • [46] NEUROPROTECTIVE EFFECT OF REDUCED GLUTATHIONE ON CISPLATIN-BASED CHEMOTHERAPY IN ADVANCED GASTRIC-CANCER - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    CASCINU, S
    CORDELLA, L
    DELFERRO, E
    FRONZONI, M
    CATALANO, G
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) : 26 - 32
  • [47] Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients
    Ozkaya, S.
    Findik, S.
    Atici, A. G.
    Dirican, A.
    NEOPLASMA, 2011, 58 (04) : 348 - 351
  • [48] A randomized, double-blind, multicenter phase 2 trial of denosumab in combination with chemotherapy as first-line treatment of metastatic non-small cell lung cancer
    Seigel, David R.
    Hirsch, Fred R.
    De Boer, Richard H.
    Natale, Ronald B.
    Crawford, Jeffrey
    Weiss, Glen J.
    Glaspy, John A.
    Fang, Amy
    Braun, Ada
    Jain, Rajul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] CISPLATIN, VINBLASTINE, AND HYDRAZINE SULFATE IN ADVANCED, NON-SMALL-CELL LUNG-CANCER - A RANDOMIZED PLACEBO-CONTROLLED, DOUBLE-BLIND PHASE-III STUDY OF THE CANCER AND LEUKEMIA GROUP-B
    KOSTY, MP
    FLEISHMAN, SB
    HERNDON, JE
    COUGHLIN, K
    KORNBLITH, AB
    SCALZO, A
    MORRIS, JC
    MORTIMER, J
    GREEN, MR
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) : 1113 - 1120
  • [50] A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer
    Jiang, Jingwei
    Liang, Xiaohua
    Zhou, Xinli
    Huang, Ruofan
    Chu, Zhaohui
    LUNG CANCER, 2007, 57 (03) : 348 - 358
12345